Perjeta and Pepcid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Perjeta (pertuzumab) and Pepcid (famotidine). Common drug interactions include hair colour changes among females.

The phase IV clinical study analyzes what interactions people have when they take Perjeta and Pepcid. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Perjeta?

Perjeta has active ingredients of pertuzumab. eHealthMe is studying from 13,388 Perjeta users. Check the latest studies of Perjeta.

What is Pepcid?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,774 Pepcid users. Check the latest studies of Pepcid.



On Jul, 15, 2026

49 people who take Perjeta and Pepcid together, and have interactions are studied.

Perjeta and Pepcid drug interactions.

What are the common drug interactions of Perjeta and Pepcid, by gender? *:

female:

  1. Hair colour changes
  2. Alopecia (absence of hair from areas of the body)
  3. Fatigue (feeling of tiredness)
  4. Nausea (feeling of having an urge to vomit)
  5. Rash
  6. Constipation
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Chills (felling of cold)
  9. Motion sickness (travel sickness)
  10. Proctalgia (pain in the rectum)

male:

n/a

What are the common drug interactions of Perjeta and Pepcid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Alopecia areata (patchy baldness that typically begins with rapid hair loss)
  2. Alopecia totalis (loss of all head hair)
  3. Constipation
  4. Decreased appetite
  5. Diarrhoea
  6. Hair colour changes
  7. Motion sickness (travel sickness)
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Proctalgia (pain in the rectum)
  10. Vomiting

30-39:

  1. Alopecia (absence of hair from areas of the body)
  2. Flushing (the warm, red condition of human skin)
  3. Hair colour changes
  4. Hair disorder
  5. Rash
  6. Urticaria (rash of round, red welts on the skin that itch intensely)
  7. Psychological trauma

40-49:

  1. Fatigue (feeling of tiredness)
  2. Abdominal pain
  3. Alopecia (absence of hair from areas of the body)
  4. Chills (felling of cold)
  5. Dacryostenosis acquired (obstruction of the nasolacrimal duct-acquired)
  6. Lacrimation increased
  7. Nausea (feeling of having an urge to vomit)
  8. Pyrexia (fever)
  9. Sneezing
  10. Vomiting

50-59:

  1. Alopecia (absence of hair from areas of the body)
  2. Hair colour changes
  3. Hair disorder
  4. Diarrhoea
  5. Nausea (feeling of having an urge to vomit)
  6. Rash
  7. Alopecia areata (patchy baldness that typically begins with rapid hair loss)
  8. Alopecia totalis (loss of all head hair)
  9. Fatigue (feeling of tiredness)
  10. Vomiting

60+:

  1. Alopecia (absence of hair from areas of the body)
  2. Diarrhoea
  3. Chest pain
  4. Chills (felling of cold)
  5. Cough
  6. Decreased appetite
  7. Dehydration (dryness resulting from the removal of water)
  8. Dyspnoea (difficult or laboured respiration)
  9. Dyspnoea exertional (breathlessness or shortness of breath)
  10. Epistaxis (bleed from the nose)

What are the existing conditions these people have? *

  1. Breast Cancer Female: 15 people, 30.61%
  2. Breast Cancer: 13 people, 26.53%
  3. Breast Cancer Metastatic: 9 people, 18.37%
  4. Stress And Anxiety: 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Perjeta and Pepcid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Perjeta and Pepcid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Perjeta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pepcid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Perjeta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pepcid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pertuzumab and famotidine (the active ingredients of Perjeta and Pepcid, respectively), and Perjeta and Pepcid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: